Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Tivantinib

EU orphan designation number: EU/3/13/1202
Active ingredient: Tivantinib
Indication: Treatment of hepatocellular carcinoma
Sponsor: Daiichi Sankyo Europe GmbH
Zielstattstraße 48, 81379 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan designation EMA/OD/115/13 (2013)8048 of 13/11/2013
10/08/2016 Transfer of orphan designation EMA/OD/115/13/T/01 (2016)5271 of 08/08/2016
21/12/2017 Removal of orphan designation from Community Register